Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support

Annals of Thoracic Surgery

Volumn 103, Issue 3, 2017, Pages 717-724

  Yoshioka, Daisuke ^a   Takayama, Hiroo ^a   Colombo, Paolo C ^a   Yuzefpolskaya, Melana ^a   Garan, Arthur R ^a   Topkara, Veli K ^a   Han, Jiho ^a   Kurlansky, Paul ^a   Naka, Yoshifumi ^a   Takeda, Koji ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; IMPLANTATION; INFECTION; KIDNEY FUNCTION; LABORATORY TEST; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; AGED; COMPLICATION; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; KIDNEY; LIVER; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME;

AGED; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KIDNEY; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 85011392093     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.12.018     Document Type: Article

References (24)

1. 1 Kirklin, J.K., Naftel, D.C., Pagani, F.D., et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34 (2015), 1495–1504.
2. 2 Slaughter, M.S., Rogers, J.G., Milano, C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
3. 3 Brisco, M.A., Kimmel, S.E., Coca, S.G., et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail 7 (2014), 68–75.
4. 4 Letsou, G.V., Myers, T.J., Gregoric, I.D., et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg 76 (2003), 1167–1170.
5. 5 Russell, S.D., Rogers, J.G., Milano, C.A., et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120 (2009), 2352–2357.
6. 6 Takayama, H., Yang, J.A., Naka, Y., Tips on tuning each device: technical pearls. Cardiol Clin 29 (2011), 551–556.
7. 7 Deo, S.V., Sharma, V., Altarabsheh, S.E., et al. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ 23 (2014), 229–233.
8. 8 Hasin, T., Topilsky, Y., Schirger, J.A., et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 59 (2012), 26–36.
9. 9 Kihara, S., Litwak, K.N., Nichols, L., et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 75 (2003), 178–183 discussion 83.
10. 10 Ambardekar, A.V., Hunter, K.S., Babu, A.N., Tuder, R.M., Dodson, R.B., Lindenfeld, J., Changes in aortic wall structure, composition, and stiffness with continuous-flow left ventricular assist devices: a pilot study. Circ Heart Fail 8 (2015), 944–952.
11. 11 Amir, O., Radovancevic, B., Delgado, R.M. 3rd, et al. Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support. J Heart Lung Transplant 25 (2006), 391–394.
12. 12 Sansone, R., Stanske, B., Keymel, S., et al. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: role of microparticles. J Heart Lung Transplant 34 (2015), 921–932.
13. 13 Ootaki, C., Yamashita, M., Ootaki, Y., et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg 136 (2008), 150–158.
14. 14 Saito, S., Westaby, S., Piggot, D., et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg 74 (2002), 1080–1085.
15. 15 Potapov, E.V., Dranishnikov, N., Morawietz, L., et al. Arterial wall histology in chronic pulsatile-flow and continuous-flow device circulatory support. J Heart Lung Transplant 31 (2012), 1171–1176.
16. 16 Sharma, A., Mucino, M.J., Ronco, C., Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract 127 (2014), 94–100.
17. 17 Akhter, S.A., Badami, A., Murray, M., et al. Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg 100 (2015), 884–889.
18. 18 Smedira, N.G., Hoercher, K.J., Lima, B., et al. Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 1 (2013), 31–39.
19. 19 Takeda, K., Takayama, H., Colombo, P.C., et al. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transplant 34 (2015), 1024–1032.
20. 20 Damman, K., van Deursen, V.M., Navis, G., Voors, A.A., van Veldhuisen, D.J., Hillege, H.L., Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53 (2009), 582–588.
21. 21 Gambardella, I., Gaudino, M., Ronco, C., Lau, C., Ivascu, N., Girardi, L.N., Congestive kidney failure in cardiac surgery: the relationship between central venous pressure and acute kidney injury. Interact Cardiovasc Thorac Surg 23 (2016), 800–805.
22. 22 Mullens, W., Abrahams, Z., Francis, G.S., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53 (2009), 589–596.
23. 23 Samsky, M.D., Patel, C.B., DeWald, T.A., et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol 61 (2013), 2397–2405.
24. 24 Yang, J.A., Kato, T.S., Shulman, B.P., et al. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 31 (2012), 601–610.